{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T22:32:03Z","timestamp":1788474723747,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ymgme.2023.107676","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T11:44:08Z","timestamp":1690976648000},"page":"107676","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["FGF21 and GDF15 are elevated in Barth Syndrome and are correlated to important clinical measures"],"prefix":"10.1016","volume":"140","author":[{"given":"Olivia","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhargava Kumar","family":"Chinni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric","family":"Manlhiot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary J.","family":"Vernon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2023.107676_bb0005","series-title":"GeneReviews((R))","article-title":"Barth Syndrome","author":"Ferreira","year":"1993"},{"key":"10.1016\/j.ymgme.2023.107676_bb0010","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1750-1172-8-70","article-title":"Natural history of Barth syndrome: a national cohort study of 22 patients","volume":"8","author":"Rigaud","year":"2013","journal-title":"Orphanet. J. Rare. Dis."},{"key":"10.1016\/j.ymgme.2023.107676_bb0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1750-1172-8-23","article-title":"Barth syndrome","volume":"8","author":"Clarke","year":"2013","journal-title":"Orphanet. J. Rare. Dis."},{"issue":"4","key":"10.1016\/j.ymgme.2023.107676_bb0020","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1086\/514886","article-title":"The X-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies","volume":"61","author":"D\u2019Adamo","year":"1997","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.ymgme.2023.107676_bb0025","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/ng0496-385","article-title":"A novel X-linked gene, G4.5. Is responsible for Barth syndrome","volume":"12","author":"Bione","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2023.107676_bb0030","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jpeds.2019.09.074","article-title":"A Bayesian analysis to determine the prevalence of Barth syndrome in the pediatric population","volume":"217","author":"Miller","year":"2020","journal-title":"J. Pediatr."},{"issue":"4","key":"10.1016\/j.ymgme.2023.107676_bb0035","first-page":"495","article-title":"Barth syndrome in male and female siblings caused by a novel mutation in the Taz gene","volume":"27","author":"Avdjieva-Tzavella","year":"2016","journal-title":"Genet. Couns."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107676_bb0040","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ymgme.2012.01.015","article-title":"Barth syndrome in a female patient","volume":"106","author":"Cosson","year":"2012","journal-title":"Mol. Genet. Metab."},{"issue":"52","key":"10.1016\/j.ymgme.2023.107676_bb0045","doi-asserted-by":"crossref","first-page":"52873","DOI":"10.1074\/jbc.M308366200","article-title":"Cardiolipin stabilizes respiratory chain supercomplexes","volume":"278","author":"Pfeiffer","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107676_bb0050","first-page":"C33","article-title":"Role of cardiolipin alterations in mitochondrial dysfunction and disease","volume":"292","author":"Chicco","year":"2007","journal-title":"Am. J. Phys. Cell Phys."},{"key":"10.1016\/j.ymgme.2023.107676_bb0055","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fcell.2017.00090","article-title":"Role of Cardiolipin in mitochondrial signaling pathways","volume":"5","author":"Dudek","year":"2017","journal-title":"Front. Cell Dev. Biol."},{"issue":"51","key":"10.1016\/j.ymgme.2023.107676_bb0060","doi-asserted-by":"crossref","first-page":"39217","DOI":"10.1074\/jbc.M606100200","article-title":"The enzymatic function of tafazzin","volume":"281","author":"Xu","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.ymgme.2023.107676_bb0065","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/gim.2015.204","article-title":"New targets for monitoring and therapy in Barth syndrome","volume":"18","author":"Thompson","year":"2016","journal-title":"Genet. Med."},{"issue":"2","key":"10.1016\/j.ymgme.2023.107676_bb0070","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ab.2009.01.032","article-title":"Cardiolipin and monolysocardiolipin analysis in fibroblasts, lymphocytes, and tissues using high-performance liquid chromatography-mass spectrometry as a diagnostic test for Barth syndrome","volume":"387","author":"Houtkooper","year":"2009","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107676_bb0075","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jimd.12425","article-title":"An improved functional assay in blood spot to diagnose Barth syndrome using the monolysocardiolipin\/cardiolipin ratio","volume":"45","author":"Vaz","year":"2022","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2023.107676_bb0080","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ymgme.2014.03.007","article-title":"Clinical laboratory studies in Barth syndrome","volume":"112","author":"Vernon","year":"2014","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2023.107676_bb0085","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/jimd.12307","article-title":"Diagnostic value of serum biomarkers FGF21 and GDF15 compared to muscle sample in mitochondrial disease","volume":"44","author":"Lehtonen","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.ymgme.2023.107676_bb0090","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1210\/jc.2011-2823","article-title":"Relationship of serum fibroblast growth factor 21 with abnormal glucose metabolism and insulin resistance: the Baltimore longitudinal study of aging","volume":"97","author":"Semba","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107676_bb0095","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10741-022-10268-0","article-title":"Fibroblast growth factor 21 in heart failure","volume":"28","author":"Tucker","year":"2023","journal-title":"Heart Fail. Rev."},{"issue":"5","key":"10.1016\/j.ymgme.2023.107676_bb0100","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.cell.2019.07.033","article-title":"GDF15 is an inflammation-induced central mediator of tissue tolerance","volume":"178","author":"Luan","year":"2019","journal-title":"Cell"},{"issue":"16","key":"10.1016\/j.ymgme.2023.107676_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168889","article-title":"GDF15 and cardiac cells: current concepts and new insights","volume":"22","author":"Rochette","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107676_bb0110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/jimd.12422","article-title":"Clinical presentation and natural history of Barth syndrome: an overview","volume":"45","author":"Taylor","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2023.107676_bb0115","first-page":"114","article-title":"Extended recovery of cardiac function after severe infantile cardiomyopathy presentation of Barth syndrome","volume":"63","author":"Yester","year":"2022","journal-title":"JIMD Rep"},{"key":"10.1016\/j.ymgme.2023.107676_bb0120","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3390\/s6070756","article-title":"Aspartate aminotransferase (AST\/GOT) and alanine aminotransferase (ALT\/GPT) detection techniques","volume":"6","author":"Huang","year":"2006","journal-title":"Sensors"},{"issue":"1","key":"10.1016\/j.ymgme.2023.107676_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.46701\/BG.2020012019123","article-title":"Electrical impedance assays of blood cells","volume":"4","author":"Gheorghiu","year":"2020","journal-title":"Blood and Genom."},{"issue":"5","key":"10.1016\/j.ymgme.2023.107676_bb0130","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/ana.24506","article-title":"Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders","volume":"78","author":"Yatsuga","year":"2015","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.ymgme.2023.107676_bb0135","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S1474-4422(11)70155-7","article-title":"FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study","volume":"10","author":"Suomalainen","year":"2011","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107676_bb0140","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1515\/CCLM.2006.016","article-title":"N-terminal pro-brain natriuretic peptide: normal ranges in the pediatric population including method comparison and interlaboratory variability","volume":"44","author":"Albers","year":"2006","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.ymgme.2023.107676_bb0145","series-title":"Biostatistical Analysis","first-page":"345","author":"Zar","year":"2010"},{"issue":"1","key":"10.1016\/j.ymgme.2023.107676_bb0150","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2307\/1412159","article-title":"The proof and measurement of association between two things","volume":"15","author":"Spearman","year":"1904","journal-title":"Am. J. Psychol."},{"key":"10.1016\/j.ymgme.2023.107676_bb0155","series-title":"Applied Longitudinal Analysis","author":"Fitzmaurice","year":"2011"},{"issue":"4","key":"10.1016\/j.ymgme.2023.107676_bb0160","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2307\/2529876","article-title":"Random-effects models for longitudinal data","volume":"38","author":"Laird","year":"1982","journal-title":"Biometrics"},{"key":"10.1016\/j.ymgme.2023.107676_bb0170","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.mgene.2015.04.001","article-title":"Structural and functional analyses of Barth syndrome-causing mutations and alternative splicing in the tafazzin acyltransferase domain","volume":"4","author":"Hijikata","year":"2015","journal-title":"Meta Gene."},{"issue":"3","key":"10.1016\/j.ymgme.2023.107676_bb0175","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/hmg\/dds447","article-title":"Seven functional classes of Barth syndrome mutation","volume":"22","author":"Whited","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2023.107676_bb0180","article-title":"Fatty acyl availability modulates Cardiolipin composition and alters mitochondrial function in HeLa cells","author":"Oemer","year":"2020","journal-title":"bioRIV"},{"issue":"16","key":"10.1016\/j.ymgme.2023.107676_bb0185","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1073\/pnas.1719407115","article-title":"Molecular structural diversity of mitochondrial cardiolipins","volume":"115","author":"Oemer","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2023.107676_bb0190","first-page":"38","article-title":"The lipid environment modulates cardiolipin and phospholipid constitution in wild type and tafazzin-deficient cells","volume":"1","author":"Oemer","year":"2021","journal-title":"J. Inherit. Metab. Dis.45"},{"issue":"12","key":"10.1016\/j.ymgme.2023.107676_bb0195","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1016\/j.celrep.2020.02.115","article-title":"Phospholipid acyl chain diversity controls the tissue-specific assembly of mitochondrial Cardiolipins","volume":"30","author":"Oemer","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymgme.2023.107676_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.601290","article-title":"FGF21: an emerging therapeutic target for non-alcoholic Steatohepatitis and related metabolic diseases","volume":"11","author":"Tillman","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"15","key":"10.1016\/j.ymgme.2023.107676_bb0205","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1136\/heartjnl-2018-314173","article-title":"Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction","volume":"105","author":"Salah","year":"2019","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.ymgme.2023.107676_bb0210","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1007\/s10741-021-10177-8","article-title":"Elamipretide for Barth syndrome cardiomyopathy: gradual rebuilding of a failed power grid","volume":"27","author":"Sabbah","year":"2022","journal-title":"Heart Fail. Rev."},{"issue":"6","key":"10.1016\/j.ymgme.2023.107676_bb0215","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/jcsm.12823","article-title":"Changes in systemic GDF15 across the adult lifespan and their impact on maximal muscle power: the Copenhagen sarcopenia study","volume":"12","author":"Alcazar","year":"2021","journal-title":"J. Cachexia. Sarcopenia Muscle"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719223003062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719223003062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T12:13:43Z","timestamp":1735215223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719223003062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1096719223003062"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2023.107676","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FGF21 and GDF15 are elevated in Barth Syndrome and are correlated to important clinical measures","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2023.107676","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107676"}}